Xueli Bai
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Surgery top 10%
- Molecular Biology
- Topics
- Pancreatic and Hepatic Oncology Research (32 papers)Cancer Immunotherapy and Biomarkers (15 papers)Gallbladder and Bile Duct Disorders (9 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Cell
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xueli Bai
60 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 993
- Pulmonary and Respiratory Medicine 448
- Immunology 447
- Surgery 427
- Molecular Biology 352
Countries citing papers authored by Xueli Bai
This map shows the geographic impact of Xueli Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueli Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueli Bai more than expected).
Fields of papers citing papers by Xueli Bai
This network shows the impact of papers produced by Xueli Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueli Bai. The network helps show where Xueli Bai may publish in the future.
Co-authorship network of co-authors of Xueli Bai
This figure shows the co-authorship network connecting the top 25 collaborators of Xueli Bai. A scholar is included among the top collaborators of Xueli Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueli Bai. Xueli Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapybreakdown → | 358 |
| 5 | 10 | |
| 6 | 9 | |
| 7 | 12 | |
| 8 | 166 | |
| 9 | 47 | |
| 10 | 107 | |
| 11 | 28 | |
| 12 | 6 | |
| 13 | 12 | |
| 14 | 10 | |
| 15 | 10 | |
| 16 | 0 | |
| 17 | 67 | |
| 18 | 11 | |
| 19 | 5 | |
| 20 | 21 |
About Xueli Bai
Xueli Bai is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (32 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Gallbladder and Bile Duct Disorders (9 papers). The work is most often cited by research in Oncology (993 citations), Immunology (447 citations) and Pulmonary and Respiratory Medicine (448 citations). Xueli Bai has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Tingbo Liang, Xing Huang, Tianyu Tang, Gang Zhang, Zhengtao Hong, Xiaozhen Zhang, Xun Wang, Enliang Li, Qi Zhang and Tao Ma. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.